Citius Pharmaceuticals (CTXR) vs Vyome (HIND)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Citius Pharmaceuticals (CTXR) has outperformed Vyome (HIND) over the past year, losing 64.2% versus a loss of 67.1%. Over five years, CTXR leads with a -99.0% price change compared with -100.0% for HIND. Vyome is the larger company by market cap ($13.9 million vs $13.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTXR | HIND |
|---|---|---|
| Share price | $0.4849 | $1.98 |
| Market cap | $13.31M | $13.90M |
| 1-day change | -3.23% | -2.94% |
| YTD return | -35.51% | -40.70% |
| 1-year return | -64.21% | -67.15% |
| 5-year return | -99.04% | -100.00% |
| P/E ratio (TTM) | — | 1.11 |
| EPS (TTM) | $-1.75 | $1.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.19 | $6.56 |
| 52-week low | $0.469 | $1.75 |
| Distance from 52-week high | -77.86% | -69.82% |
| Average volume | 528.79K | 13.60K |
| Shares outstanding | 27.45M | 7.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CTXR vs HIND FAQ
Which is bigger, Citius Pharmaceuticals or Vyome?
Vyome (HIND) is larger, with a market capitalization of $13.90M compared with $13.31M for Citius Pharmaceuticals (CTXR).
Which stock has performed better over the past year, CTXR or HIND?
CTXR returned -64.21% over the past 12 months, compared with -67.15% for HIND (price return, excluding dividends). Past performance does not predict future results.
Are Citius Pharmaceuticals and Vyome in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.